Strnad V, Tacev T, Prokes B, Ott O, Krystof V, Svobodova M, Rasovska O, Konecny M
Research Institute of Clinical and Experimental Oncology, Department of Radiotherapy, Brno, Czechoslovakia.
Strahlenther Onkol. 1990 Nov;166(11):728-32.
The response of primary tumor to definitive radiation therapy and treatment related morbidity has been analysed in a group of 35 patients. All of them were treated with 20 MeV photon beam to a total dose of 67 to 71 Gy to the prostate. The effect of radiotherapy to a primary tumor were evaluated by means of repeated CT examination of the tumor volume. A statistically significant tumor regression was found to occur from the sixth month after finishing radiotherapy. The absolute majority of treatment complications was of the first grade. Neither moderate nor severe gastrointestinal or genitourinary complications were recorded. The follow-up data of our patients have confirmed that radiotherapy in localized prostatic carcinoma, when sophisticated techniques are employed, represents highly effective treatment modality which improved the quality of life in patients with prostate cancer.
对35例患者的原发性肿瘤对根治性放射治疗的反应及治疗相关的发病率进行了分析。所有患者均接受20 MeV光子束治疗,前列腺总剂量为67至71 Gy。通过对肿瘤体积进行重复CT检查来评估放疗对原发性肿瘤的效果。发现放疗结束后第六个月出现了具有统计学意义的肿瘤消退。治疗并发症绝大多数为1级。未记录到中度或重度胃肠道或泌尿生殖系统并发症。我们患者的随访数据证实,在局部前列腺癌中采用先进技术进行放疗是一种高效的治疗方式,可改善前列腺癌患者的生活质量。